nodes	percent_of_prediction	percent_of_DWPC	metapath
Metronidazole—CYP2C8—Paclitaxel—ovarian cancer	0.11	0.249	CbGbCtD
Metronidazole—CYP3A4—Topotecan—ovarian cancer	0.0899	0.204	CbGbCtD
Metronidazole—CYP2C9—Paclitaxel—ovarian cancer	0.0766	0.174	CbGbCtD
Metronidazole—CYP3A4—Vinorelbine—ovarian cancer	0.0634	0.144	CbGbCtD
Metronidazole—CYP3A4—Paclitaxel—ovarian cancer	0.0445	0.101	CbGbCtD
Metronidazole—CYP3A4—Docetaxel—ovarian cancer	0.0322	0.0731	CbGbCtD
Metronidazole—CYP3A4—Doxorubicin—ovarian cancer	0.024	0.0545	CbGbCtD
Metronidazole—Neutropenia—Epirubicin—ovarian cancer	0.000342	0.000611	CcSEcCtD
Metronidazole—Rash—Vinorelbine—ovarian cancer	0.000341	0.000609	CcSEcCtD
Metronidazole—Dermatitis—Vinorelbine—ovarian cancer	0.000341	0.000609	CcSEcCtD
Metronidazole—Abdominal distension—Doxorubicin—ovarian cancer	0.000341	0.000609	CcSEcCtD
Metronidazole—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.00034	0.000607	CcSEcCtD
Metronidazole—Headache—Vinorelbine—ovarian cancer	0.000339	0.000605	CcSEcCtD
Metronidazole—Syncope—Docetaxel—ovarian cancer	0.000339	0.000605	CcSEcCtD
Metronidazole—Influenza—Doxorubicin—ovarian cancer	0.000338	0.000605	CcSEcCtD
Metronidazole—Asthma—Doxorubicin—ovarian cancer	0.000338	0.000605	CcSEcCtD
Metronidazole—Leukopenia—Docetaxel—ovarian cancer	0.000338	0.000604	CcSEcCtD
Metronidazole—Pollakiuria—Epirubicin—ovarian cancer	0.000338	0.000604	CcSEcCtD
Metronidazole—Eosinophilia—Doxorubicin—ovarian cancer	0.000335	0.000599	CcSEcCtD
Metronidazole—Palpitations—Docetaxel—ovarian cancer	0.000334	0.000596	CcSEcCtD
Metronidazole—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000334	0.000596	CcSEcCtD
Metronidazole—Loss of consciousness—Docetaxel—ovarian cancer	0.000332	0.000593	CcSEcCtD
Metronidazole—Pancreatitis—Doxorubicin—ovarian cancer	0.000332	0.000593	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000331	0.000592	CcSEcCtD
Metronidazole—Insomnia—Paclitaxel—ovarian cancer	0.000329	0.000588	CcSEcCtD
Metronidazole—Convulsion—Docetaxel—ovarian cancer	0.000327	0.000585	CcSEcCtD
Metronidazole—Paraesthesia—Paclitaxel—ovarian cancer	0.000327	0.000584	CcSEcCtD
Metronidazole—Hypertension—Docetaxel—ovarian cancer	0.000326	0.000583	CcSEcCtD
Metronidazole—Infestation NOS—Epirubicin—ovarian cancer	0.000326	0.000583	CcSEcCtD
Metronidazole—Drowsiness—Epirubicin—ovarian cancer	0.000326	0.000583	CcSEcCtD
Metronidazole—Infestation—Epirubicin—ovarian cancer	0.000326	0.000583	CcSEcCtD
Metronidazole—Bronchitis—Doxorubicin—ovarian cancer	0.000325	0.000581	CcSEcCtD
Metronidazole—Somnolence—Paclitaxel—ovarian cancer	0.000323	0.000578	CcSEcCtD
Metronidazole—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000323	0.000578	CcSEcCtD
Metronidazole—Chest pain—Docetaxel—ovarian cancer	0.000322	0.000575	CcSEcCtD
Metronidazole—Arthralgia—Docetaxel—ovarian cancer	0.000322	0.000575	CcSEcCtD
Metronidazole—Pancytopenia—Doxorubicin—ovarian cancer	0.000321	0.000574	CcSEcCtD
Metronidazole—Nausea—Vinorelbine—ovarian cancer	0.000321	0.000574	CcSEcCtD
Metronidazole—Dyspepsia—Paclitaxel—ovarian cancer	0.00032	0.000572	CcSEcCtD
Metronidazole—Neuropathy peripheral—Epirubicin—ovarian cancer	0.00032	0.000571	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000319	0.000571	CcSEcCtD
Metronidazole—Jaundice—Epirubicin—ovarian cancer	0.000318	0.000568	CcSEcCtD
Metronidazole—Stomatitis—Epirubicin—ovarian cancer	0.000318	0.000568	CcSEcCtD
Metronidazole—Conjunctivitis—Epirubicin—ovarian cancer	0.000317	0.000566	CcSEcCtD
Metronidazole—Urinary tract infection—Epirubicin—ovarian cancer	0.000317	0.000566	CcSEcCtD
Metronidazole—Neutropenia—Doxorubicin—ovarian cancer	0.000316	0.000565	CcSEcCtD
Metronidazole—Dysuria—Doxorubicin—ovarian cancer	0.000316	0.000565	CcSEcCtD
Metronidazole—Decreased appetite—Paclitaxel—ovarian cancer	0.000316	0.000565	CcSEcCtD
Metronidazole—Dry mouth—Docetaxel—ovarian cancer	0.000315	0.000562	CcSEcCtD
Metronidazole—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000314	0.000562	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000314	0.000561	CcSEcCtD
Metronidazole—Fatigue—Paclitaxel—ovarian cancer	0.000314	0.00056	CcSEcCtD
Metronidazole—Sweating—Epirubicin—ovarian cancer	0.000313	0.000558	CcSEcCtD
Metronidazole—Pollakiuria—Doxorubicin—ovarian cancer	0.000313	0.000558	CcSEcCtD
Metronidazole—Pain—Paclitaxel—ovarian cancer	0.000311	0.000556	CcSEcCtD
Metronidazole—Constipation—Paclitaxel—ovarian cancer	0.000311	0.000556	CcSEcCtD
Metronidazole—Confusional state—Docetaxel—ovarian cancer	0.000311	0.000555	CcSEcCtD
Metronidazole—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000309	0.000552	CcSEcCtD
Metronidazole—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000308	0.000551	CcSEcCtD
Metronidazole—Anaphylactic shock—Docetaxel—ovarian cancer	0.000308	0.000551	CcSEcCtD
Metronidazole—Oedema—Docetaxel—ovarian cancer	0.000308	0.000551	CcSEcCtD
Metronidazole—Infection—Docetaxel—ovarian cancer	0.000306	0.000547	CcSEcCtD
Metronidazole—Sinusitis—Epirubicin—ovarian cancer	0.000306	0.000547	CcSEcCtD
Metronidazole—Agranulocytosis—Epirubicin—ovarian cancer	0.000304	0.000544	CcSEcCtD
Metronidazole—Shock—Docetaxel—ovarian cancer	0.000303	0.000542	CcSEcCtD
Metronidazole—Nervous system disorder—Docetaxel—ovarian cancer	0.000302	0.00054	CcSEcCtD
Metronidazole—Thrombocytopenia—Docetaxel—ovarian cancer	0.000302	0.000539	CcSEcCtD
Metronidazole—Infestation—Doxorubicin—ovarian cancer	0.000302	0.000539	CcSEcCtD
Metronidazole—Infestation NOS—Doxorubicin—ovarian cancer	0.000302	0.000539	CcSEcCtD
Metronidazole—Drowsiness—Doxorubicin—ovarian cancer	0.000302	0.000539	CcSEcCtD
Metronidazole—Feeling abnormal—Paclitaxel—ovarian cancer	0.0003	0.000536	CcSEcCtD
Metronidazole—Skin disorder—Docetaxel—ovarian cancer	0.000299	0.000535	CcSEcCtD
Metronidazole—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000299	0.000534	CcSEcCtD
Metronidazole—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000297	0.000531	CcSEcCtD
Metronidazole—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000296	0.000528	CcSEcCtD
Metronidazole—Stomatitis—Doxorubicin—ovarian cancer	0.000294	0.000525	CcSEcCtD
Metronidazole—Jaundice—Doxorubicin—ovarian cancer	0.000294	0.000525	CcSEcCtD
Metronidazole—Anorexia—Docetaxel—ovarian cancer	0.000294	0.000525	CcSEcCtD
Metronidazole—Rhinitis—Epirubicin—ovarian cancer	0.000293	0.000524	CcSEcCtD
Metronidazole—Conjunctivitis—Doxorubicin—ovarian cancer	0.000293	0.000524	CcSEcCtD
Metronidazole—Urinary tract infection—Doxorubicin—ovarian cancer	0.000293	0.000524	CcSEcCtD
Metronidazole—Hepatitis—Epirubicin—ovarian cancer	0.000293	0.000523	CcSEcCtD
Metronidazole—Hypoaesthesia—Epirubicin—ovarian cancer	0.000291	0.00052	CcSEcCtD
Metronidazole—Pharyngitis—Epirubicin—ovarian cancer	0.000291	0.000519	CcSEcCtD
Metronidazole—Sweating—Doxorubicin—ovarian cancer	0.000289	0.000517	CcSEcCtD
Metronidazole—Urticaria—Paclitaxel—ovarian cancer	0.000289	0.000516	CcSEcCtD
Metronidazole—Connective tissue disorder—Epirubicin—ovarian cancer	0.000288	0.000514	CcSEcCtD
Metronidazole—Abdominal pain—Paclitaxel—ovarian cancer	0.000288	0.000514	CcSEcCtD
Metronidazole—Body temperature increased—Paclitaxel—ovarian cancer	0.000288	0.000514	CcSEcCtD
Metronidazole—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000285	0.00051	CcSEcCtD
Metronidazole—Sinusitis—Doxorubicin—ovarian cancer	0.000283	0.000506	CcSEcCtD
Metronidazole—Visual impairment—Epirubicin—ovarian cancer	0.000282	0.000504	CcSEcCtD
Metronidazole—Agranulocytosis—Doxorubicin—ovarian cancer	0.000282	0.000503	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000281	0.000502	CcSEcCtD
Metronidazole—Insomnia—Docetaxel—ovarian cancer	0.000279	0.000498	CcSEcCtD
Metronidazole—Paraesthesia—Docetaxel—ovarian cancer	0.000277	0.000495	CcSEcCtD
Metronidazole—Erythema multiforme—Epirubicin—ovarian cancer	0.000277	0.000494	CcSEcCtD
Metronidazole—Somnolence—Docetaxel—ovarian cancer	0.000274	0.00049	CcSEcCtD
Metronidazole—Eye disorder—Epirubicin—ovarian cancer	0.000274	0.000489	CcSEcCtD
Metronidazole—Tinnitus—Epirubicin—ovarian cancer	0.000273	0.000488	CcSEcCtD
Metronidazole—Flushing—Epirubicin—ovarian cancer	0.000272	0.000485	CcSEcCtD
Metronidazole—Cardiac disorder—Epirubicin—ovarian cancer	0.000272	0.000485	CcSEcCtD
Metronidazole—Rhinitis—Doxorubicin—ovarian cancer	0.000272	0.000485	CcSEcCtD
Metronidazole—Dyspepsia—Docetaxel—ovarian cancer	0.000271	0.000485	CcSEcCtD
Metronidazole—Hepatitis—Doxorubicin—ovarian cancer	0.000271	0.000484	CcSEcCtD
Metronidazole—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000269	0.000481	CcSEcCtD
Metronidazole—Pharyngitis—Doxorubicin—ovarian cancer	0.000269	0.00048	CcSEcCtD
Metronidazole—Decreased appetite—Docetaxel—ovarian cancer	0.000268	0.000479	CcSEcCtD
Metronidazole—Hypersensitivity—Paclitaxel—ovarian cancer	0.000268	0.000479	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000266	0.000476	CcSEcCtD
Metronidazole—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000266	0.000475	CcSEcCtD
Metronidazole—Fatigue—Docetaxel—ovarian cancer	0.000266	0.000475	CcSEcCtD
Metronidazole—Angiopathy—Epirubicin—ovarian cancer	0.000266	0.000474	CcSEcCtD
Metronidazole—Immune system disorder—Epirubicin—ovarian cancer	0.000264	0.000472	CcSEcCtD
Metronidazole—Mediastinal disorder—Epirubicin—ovarian cancer	0.000264	0.000471	CcSEcCtD
Metronidazole—Pain—Docetaxel—ovarian cancer	0.000264	0.000471	CcSEcCtD
Metronidazole—Constipation—Docetaxel—ovarian cancer	0.000264	0.000471	CcSEcCtD
Metronidazole—Visual impairment—Doxorubicin—ovarian cancer	0.000261	0.000466	CcSEcCtD
Metronidazole—Asthenia—Paclitaxel—ovarian cancer	0.000261	0.000466	CcSEcCtD
Metronidazole—Pruritus—Paclitaxel—ovarian cancer	0.000257	0.00046	CcSEcCtD
Metronidazole—Mental disorder—Epirubicin—ovarian cancer	0.000256	0.000458	CcSEcCtD
Metronidazole—Erythema multiforme—Doxorubicin—ovarian cancer	0.000256	0.000458	CcSEcCtD
Metronidazole—Erythema—Epirubicin—ovarian cancer	0.000255	0.000455	CcSEcCtD
Metronidazole—Feeling abnormal—Docetaxel—ovarian cancer	0.000254	0.000454	CcSEcCtD
Metronidazole—Eye disorder—Doxorubicin—ovarian cancer	0.000253	0.000452	CcSEcCtD
Metronidazole—Tinnitus—Doxorubicin—ovarian cancer	0.000253	0.000451	CcSEcCtD
Metronidazole—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000252	0.00045	CcSEcCtD
Metronidazole—Cardiac disorder—Doxorubicin—ovarian cancer	0.000251	0.000449	CcSEcCtD
Metronidazole—Flushing—Doxorubicin—ovarian cancer	0.000251	0.000449	CcSEcCtD
Metronidazole—Flatulence—Epirubicin—ovarian cancer	0.000251	0.000449	CcSEcCtD
Metronidazole—Dysgeusia—Epirubicin—ovarian cancer	0.00025	0.000446	CcSEcCtD
Metronidazole—Diarrhoea—Paclitaxel—ovarian cancer	0.000249	0.000445	CcSEcCtD
Metronidazole—Back pain—Epirubicin—ovarian cancer	0.000246	0.00044	CcSEcCtD
Metronidazole—Angiopathy—Doxorubicin—ovarian cancer	0.000246	0.000439	CcSEcCtD
Metronidazole—Muscle spasms—Epirubicin—ovarian cancer	0.000245	0.000438	CcSEcCtD
Metronidazole—Immune system disorder—Doxorubicin—ovarian cancer	0.000245	0.000437	CcSEcCtD
Metronidazole—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000244	0.000436	CcSEcCtD
Metronidazole—Abdominal pain—Docetaxel—ovarian cancer	0.000244	0.000435	CcSEcCtD
Metronidazole—Body temperature increased—Docetaxel—ovarian cancer	0.000244	0.000435	CcSEcCtD
Metronidazole—Dizziness—Paclitaxel—ovarian cancer	0.000241	0.00043	CcSEcCtD
Metronidazole—Vision blurred—Epirubicin—ovarian cancer	0.00024	0.000429	CcSEcCtD
Metronidazole—Mental disorder—Doxorubicin—ovarian cancer	0.000237	0.000424	CcSEcCtD
Metronidazole—Erythema—Doxorubicin—ovarian cancer	0.000236	0.000421	CcSEcCtD
Metronidazole—Flatulence—Doxorubicin—ovarian cancer	0.000232	0.000415	CcSEcCtD
Metronidazole—Vomiting—Paclitaxel—ovarian cancer	0.000231	0.000413	CcSEcCtD
Metronidazole—Dysgeusia—Doxorubicin—ovarian cancer	0.000231	0.000412	CcSEcCtD
Metronidazole—Malaise—Epirubicin—ovarian cancer	0.00023	0.000411	CcSEcCtD
Metronidazole—Rash—Paclitaxel—ovarian cancer	0.000229	0.00041	CcSEcCtD
Metronidazole—Dermatitis—Paclitaxel—ovarian cancer	0.000229	0.000409	CcSEcCtD
Metronidazole—Vertigo—Epirubicin—ovarian cancer	0.000229	0.000409	CcSEcCtD
Metronidazole—Syncope—Epirubicin—ovarian cancer	0.000229	0.000408	CcSEcCtD
Metronidazole—Leukopenia—Epirubicin—ovarian cancer	0.000228	0.000407	CcSEcCtD
Metronidazole—Back pain—Doxorubicin—ovarian cancer	0.000228	0.000407	CcSEcCtD
Metronidazole—Headache—Paclitaxel—ovarian cancer	0.000228	0.000407	CcSEcCtD
Metronidazole—Hypersensitivity—Docetaxel—ovarian cancer	0.000227	0.000406	CcSEcCtD
Metronidazole—Muscle spasms—Doxorubicin—ovarian cancer	0.000227	0.000405	CcSEcCtD
Metronidazole—Palpitations—Epirubicin—ovarian cancer	0.000225	0.000402	CcSEcCtD
Metronidazole—Loss of consciousness—Epirubicin—ovarian cancer	0.000224	0.0004	CcSEcCtD
Metronidazole—Vision blurred—Doxorubicin—ovarian cancer	0.000222	0.000397	CcSEcCtD
Metronidazole—Asthenia—Docetaxel—ovarian cancer	0.000221	0.000395	CcSEcCtD
Metronidazole—Convulsion—Epirubicin—ovarian cancer	0.000221	0.000394	CcSEcCtD
Metronidazole—Hypertension—Epirubicin—ovarian cancer	0.00022	0.000393	CcSEcCtD
Metronidazole—Pruritus—Docetaxel—ovarian cancer	0.000218	0.00039	CcSEcCtD
Metronidazole—Arthralgia—Epirubicin—ovarian cancer	0.000217	0.000388	CcSEcCtD
Metronidazole—Chest pain—Epirubicin—ovarian cancer	0.000217	0.000388	CcSEcCtD
Metronidazole—Nausea—Paclitaxel—ovarian cancer	0.000216	0.000386	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000215	0.000385	CcSEcCtD
Metronidazole—Malaise—Doxorubicin—ovarian cancer	0.000213	0.00038	CcSEcCtD
Metronidazole—Dry mouth—Epirubicin—ovarian cancer	0.000212	0.000379	CcSEcCtD
Metronidazole—Vertigo—Doxorubicin—ovarian cancer	0.000212	0.000378	CcSEcCtD
Metronidazole—Syncope—Doxorubicin—ovarian cancer	0.000211	0.000378	CcSEcCtD
Metronidazole—Leukopenia—Doxorubicin—ovarian cancer	0.000211	0.000377	CcSEcCtD
Metronidazole—Diarrhoea—Docetaxel—ovarian cancer	0.000211	0.000377	CcSEcCtD
Metronidazole—Confusional state—Epirubicin—ovarian cancer	0.00021	0.000375	CcSEcCtD
Metronidazole—Palpitations—Doxorubicin—ovarian cancer	0.000208	0.000372	CcSEcCtD
Metronidazole—Anaphylactic shock—Epirubicin—ovarian cancer	0.000208	0.000372	CcSEcCtD
Metronidazole—Oedema—Epirubicin—ovarian cancer	0.000208	0.000372	CcSEcCtD
Metronidazole—Loss of consciousness—Doxorubicin—ovarian cancer	0.000207	0.00037	CcSEcCtD
Metronidazole—Infection—Epirubicin—ovarian cancer	0.000207	0.000369	CcSEcCtD
Metronidazole—Shock—Epirubicin—ovarian cancer	0.000205	0.000366	CcSEcCtD
Metronidazole—Convulsion—Doxorubicin—ovarian cancer	0.000204	0.000365	CcSEcCtD
Metronidazole—Nervous system disorder—Epirubicin—ovarian cancer	0.000204	0.000364	CcSEcCtD
Metronidazole—Dizziness—Docetaxel—ovarian cancer	0.000204	0.000364	CcSEcCtD
Metronidazole—Thrombocytopenia—Epirubicin—ovarian cancer	0.000204	0.000364	CcSEcCtD
Metronidazole—Hypertension—Doxorubicin—ovarian cancer	0.000204	0.000364	CcSEcCtD
Metronidazole—Skin disorder—Epirubicin—ovarian cancer	0.000202	0.000361	CcSEcCtD
Metronidazole—Hyperhidrosis—Epirubicin—ovarian cancer	0.000201	0.000359	CcSEcCtD
Metronidazole—Arthralgia—Doxorubicin—ovarian cancer	0.000201	0.000359	CcSEcCtD
Metronidazole—Chest pain—Doxorubicin—ovarian cancer	0.000201	0.000359	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000199	0.000356	CcSEcCtD
Metronidazole—Anorexia—Epirubicin—ovarian cancer	0.000198	0.000354	CcSEcCtD
Metronidazole—Dry mouth—Doxorubicin—ovarian cancer	0.000196	0.000351	CcSEcCtD
Metronidazole—Vomiting—Docetaxel—ovarian cancer	0.000196	0.00035	CcSEcCtD
Metronidazole—Rash—Docetaxel—ovarian cancer	0.000194	0.000347	CcSEcCtD
Metronidazole—Dermatitis—Docetaxel—ovarian cancer	0.000194	0.000347	CcSEcCtD
Metronidazole—Confusional state—Doxorubicin—ovarian cancer	0.000194	0.000347	CcSEcCtD
Metronidazole—Headache—Docetaxel—ovarian cancer	0.000193	0.000345	CcSEcCtD
Metronidazole—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000192	0.000344	CcSEcCtD
Metronidazole—Oedema—Doxorubicin—ovarian cancer	0.000192	0.000344	CcSEcCtD
Metronidazole—Infection—Doxorubicin—ovarian cancer	0.000191	0.000342	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000189	0.000338	CcSEcCtD
Metronidazole—Shock—Doxorubicin—ovarian cancer	0.000189	0.000338	CcSEcCtD
Metronidazole—Nervous system disorder—Doxorubicin—ovarian cancer	0.000189	0.000337	CcSEcCtD
Metronidazole—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000188	0.000337	CcSEcCtD
Metronidazole—Insomnia—Epirubicin—ovarian cancer	0.000188	0.000336	CcSEcCtD
Metronidazole—Skin disorder—Doxorubicin—ovarian cancer	0.000187	0.000334	CcSEcCtD
Metronidazole—Paraesthesia—Epirubicin—ovarian cancer	0.000187	0.000334	CcSEcCtD
Metronidazole—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000186	0.000332	CcSEcCtD
Metronidazole—Somnolence—Epirubicin—ovarian cancer	0.000185	0.00033	CcSEcCtD
Metronidazole—Anorexia—Doxorubicin—ovarian cancer	0.000183	0.000328	CcSEcCtD
Metronidazole—Nausea—Docetaxel—ovarian cancer	0.000183	0.000327	CcSEcCtD
Metronidazole—Dyspepsia—Epirubicin—ovarian cancer	0.000183	0.000327	CcSEcCtD
Metronidazole—Decreased appetite—Epirubicin—ovarian cancer	0.000181	0.000323	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.00018	0.000321	CcSEcCtD
Metronidazole—Fatigue—Epirubicin—ovarian cancer	0.000179	0.00032	CcSEcCtD
Metronidazole—Pain—Epirubicin—ovarian cancer	0.000178	0.000318	CcSEcCtD
Metronidazole—Constipation—Epirubicin—ovarian cancer	0.000178	0.000318	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000175	0.000313	CcSEcCtD
Metronidazole—Insomnia—Doxorubicin—ovarian cancer	0.000174	0.000311	CcSEcCtD
Metronidazole—Paraesthesia—Doxorubicin—ovarian cancer	0.000173	0.000309	CcSEcCtD
Metronidazole—Feeling abnormal—Epirubicin—ovarian cancer	0.000171	0.000306	CcSEcCtD
Metronidazole—Somnolence—Doxorubicin—ovarian cancer	0.000171	0.000306	CcSEcCtD
Metronidazole—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00017	0.000304	CcSEcCtD
Metronidazole—Dyspepsia—Doxorubicin—ovarian cancer	0.000169	0.000303	CcSEcCtD
Metronidazole—Decreased appetite—Doxorubicin—ovarian cancer	0.000167	0.000299	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000166	0.000297	CcSEcCtD
Metronidazole—Fatigue—Doxorubicin—ovarian cancer	0.000166	0.000296	CcSEcCtD
Metronidazole—Urticaria—Epirubicin—ovarian cancer	0.000165	0.000295	CcSEcCtD
Metronidazole—Pain—Doxorubicin—ovarian cancer	0.000165	0.000294	CcSEcCtD
Metronidazole—Constipation—Doxorubicin—ovarian cancer	0.000165	0.000294	CcSEcCtD
Metronidazole—Abdominal pain—Epirubicin—ovarian cancer	0.000164	0.000294	CcSEcCtD
Metronidazole—Body temperature increased—Epirubicin—ovarian cancer	0.000164	0.000294	CcSEcCtD
Metronidazole—Feeling abnormal—Doxorubicin—ovarian cancer	0.000159	0.000283	CcSEcCtD
Metronidazole—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000157	0.000281	CcSEcCtD
Metronidazole—Hypersensitivity—Epirubicin—ovarian cancer	0.000153	0.000274	CcSEcCtD
Metronidazole—Urticaria—Doxorubicin—ovarian cancer	0.000153	0.000273	CcSEcCtD
Metronidazole—Body temperature increased—Doxorubicin—ovarian cancer	0.000152	0.000272	CcSEcCtD
Metronidazole—Abdominal pain—Doxorubicin—ovarian cancer	0.000152	0.000272	CcSEcCtD
Metronidazole—Asthenia—Epirubicin—ovarian cancer	0.000149	0.000267	CcSEcCtD
Metronidazole—Pruritus—Epirubicin—ovarian cancer	0.000147	0.000263	CcSEcCtD
Metronidazole—Diarrhoea—Epirubicin—ovarian cancer	0.000142	0.000254	CcSEcCtD
Metronidazole—Hypersensitivity—Doxorubicin—ovarian cancer	0.000142	0.000253	CcSEcCtD
Metronidazole—Asthenia—Doxorubicin—ovarian cancer	0.000138	0.000247	CcSEcCtD
Metronidazole—Dizziness—Epirubicin—ovarian cancer	0.000138	0.000246	CcSEcCtD
Metronidazole—Pruritus—Doxorubicin—ovarian cancer	0.000136	0.000243	CcSEcCtD
Metronidazole—Vomiting—Epirubicin—ovarian cancer	0.000132	0.000236	CcSEcCtD
Metronidazole—Diarrhoea—Doxorubicin—ovarian cancer	0.000132	0.000235	CcSEcCtD
Metronidazole—Rash—Epirubicin—ovarian cancer	0.000131	0.000234	CcSEcCtD
Metronidazole—Dermatitis—Epirubicin—ovarian cancer	0.000131	0.000234	CcSEcCtD
Metronidazole—Headache—Epirubicin—ovarian cancer	0.00013	0.000233	CcSEcCtD
Metronidazole—Dizziness—Doxorubicin—ovarian cancer	0.000127	0.000227	CcSEcCtD
Metronidazole—Nausea—Epirubicin—ovarian cancer	0.000124	0.000221	CcSEcCtD
Metronidazole—Vomiting—Doxorubicin—ovarian cancer	0.000122	0.000219	CcSEcCtD
Metronidazole—Rash—Doxorubicin—ovarian cancer	0.000121	0.000217	CcSEcCtD
Metronidazole—Dermatitis—Doxorubicin—ovarian cancer	0.000121	0.000217	CcSEcCtD
Metronidazole—Headache—Doxorubicin—ovarian cancer	0.000121	0.000215	CcSEcCtD
Metronidazole—Nausea—Doxorubicin—ovarian cancer	0.000114	0.000204	CcSEcCtD
